Multiple Sclerosis, menopause and hormone replacement therapy
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Estradiol
Estrogen receptor alpha agonist
What it measured
Main measures
Disease progression:
Other measures (1)
Objective cognitive functions: statistically significant difference between the test results in the beginning and in the end
Thinking and memory
Who could take part
MS (type not specified)
Inclusion: - Gender: female Exclusion: - Course of disease: primary or secondary progressive multiple sclerosis or clinically isolated syndrome
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To define the effect of menopause on clinical picture, physical and cognitive functions and quality of life in female with relapsing-remitting multiple sclerosis.
Loading reviews and guidelines…
Related trials
- Oral Testosterone for Fatigue in Male Multiple Sclerosis …
Phase 2 · Stopped early
Stopped early
- POPART`MUS
Phase 3 · Ongoing
Still running
- A Trial to Investigate the Effectiveness of Testosterone …
Phase 2 · Withdrawn
Stopped early
History
Started
Dec 2014
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error